๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Controlled Release of IGF-1 and HGF from a Biodegradable Polyurethane Scaffold

โœ Scribed by Devin M. Nelson; Priya R. Baraniak; Zuwei Ma; Jianjun Guan; N. Scott Mason; William R. Wagner


Book ID
106494187
Publisher
Springer US
Year
2011
Tongue
English
Weight
885 KB
Volume
28
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Controlled drug release from a novel inj
โœ Diederik H. R. Kempen; Lichun Lu; Choll Kim; Xun Zhu; Wouter J. A. Dhert; Bradfo ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB

## Abstract The ideal biomaterial for the repair of bone defects is expected to have good mechanical properties, be fabricated easily into a desired shape, support cell attachment, allow controlled release of bioactive factors to induce bone formation, and biodegrade into nontoxic products to permi

Controlled release of transforming growt
โœ Lu, Lichun ;Stamatas, Georgios N. ;Mikos, Antonios G. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Recombinant human transforming growth factor โค1 (TGF-โค1) was incorporated into biodegradable microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) at 6 ng/1 mg microparticles. Fluorescein isothiocynate labeled bovine serum albumin (FITC-BSA) was coencaps

Sequential release of bioactive IGF-I an
โœ Ana Jaklenec; Alexandra Hinckfuss; Bahar Bilgen; Deborah M. Ciombor; Roy Aaron; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 368 KB

Growth factors have become an important component for tissue engineering and regenerative medicine. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta1 (TGF-beta 1) in particular have great significance in cartilage tissue engineering. Here, we describe sequential release of IG

Controlled release of bisphosphonate fro
โœ Dr. Gershon Golomb; Matilda Levi; Joel M. Van Gelder ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 482 KB

The present investigation describes the formulation and the in vivo efficacy of prolonged controlled-release chitosan matrices, containing the novel anticalcification agents adipoyland suberoylbisphosphonate (AdBP and SuBP). Chitosan matrices were prepared by the solvent-cast method and the role of